2BB score and signals
Nurix Therapeutics, Inc.’s current 2BB score is 46 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 69 | High |
| Momentum | 60 | Stable |
| Financial strength | 20 | Very Weak |
| Quality | 98 | Very Strong |
| Risk | 37 | Low |
Company facts
| Headquarters | Brisbane, California, United States |
| Founded | 2009 |
| Employees | 317 |
| P/E ratio | 10.24 |
| 52-week range | $9.18 – $28.23 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-04-06 | — | -0.5406 | — | $19.48M |
| 2027-01-26 | — | -0.1207 | — | $28.43M |
| 2026-10-07 | — | -0.6129 | — | $24.77M |
| 2026-07-09 | -0.81 | -0.7312 | $9.04M | $16.49M |
Related companies
